Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

The Benefits and Long-Term Effects of Presymptomatic Treatment

Program Overview

In this module, Julie Parsons, MD, along with Claudia Chiriboga, MD, MPH, course chair, will review the benefits and long-term effects of presymptomatic treatment for patients with spinal muscular atrophy (SMA). The faculty will discuss the benefits of early disease diagnosis and how to implement presymptomatic treatment in infants with SMA. Upon completion of this 30-minute module, clinicians ...
View Course
Review of Current and Emerging Therapeutic Options for Patients with SMA

Program Overview

In this module, Basil Darras, MD, along with Claudia Chiriboga, MD, MPH, course chair, will analyze current and emerging therapeutic options for patients with spinal muscular atrophy (SMA). The faculty will review recent data of both available and investigational therapeutic options for the treatment of patients with SMA. Upon completion of this 30-minute module, learners will gain insight ...
View Course
Applications of Genetic Screening for SMA

Program Overview

In this module, Wendy Chung, MD, PhD, along with Claudia Chiriboga, MD, MPH, course chair, will review the applications of genetic screening for patients with spinal musical atrophy (SMA). The faculty will discuss updates in screening techniques, as well as advances in genetic testing for infants with SMA. Upon completion of this 30-minute module, clinicians will be better ...
View Course
Virtual CureSMA 2020 Data Review and Analyses

Program Overview

In this module, John Brandsema MD, along with Claudia Chiriboga, MD, MPH, course chair, will review information released at the Virtual CureSMA Conference 2020. Dr. Brandsema will provide an in-depth overview of recent clinical trial data of current and emerging therapeutics for SMA, and the expert faculty will dive into a discussion on the details of these clinical ...
View Course
Managing SMA Patients During the COVID-19 Pandemic – CureSMA

Program Overview

In this module, Oscar Henry Mayer, MD, along with Claudia Chiriboga, MD, MPH, course chair, will discuss strategies for managing spinal muscular atrophy (SMA) patients during the COVID-19 pandemic. Current clinical recommendations from CureSMA for the management of patients with SMA will be reviewed during the interview segment. Best practices for avoiding care disruption for SMA patients during ...
View Course
Advances in Sphingosine-1-phosphate (S1P) Therapeutics to Improve Outcomes in Patients with Inflammatory Bowel Disease

Program Overview

This CME activity will highlight advances in sphinogosine-1-phosphate (S1P) therapeutics to improve outcomes in patients with inflammatory bowel disease. The expert faculty, led by Dr. William Sandborn, will discuss how sphingosine-1-phosphate (S1P) receptor modulators are utilized as a therapeutic target to reduce inflammation in patients with inflammatory bowel disease (IBD). Recent and emerging clinical trial data on the ...
View Course

Upcoming Events

Alliance 46th Annual Conference

July 14th – 16th, 2021

CCR East Annual Meeting

August 12th-15th, 2021

CCR West Annual Meeting

September 18th – 21st, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021